These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 32735220)

  • 1. Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers.
    Thomas BE; Kumar JV; Onongaya C; Bhatt SN; Galivanche A; Periyasamy M; Chiranjeevi M; Khandewale AS; Ramachandran G; Shah D; Haberer JE; Mayer KH; Subbaraman R
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e16634. PubMed ID: 32735220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
    Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
    J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study.
    Leddy A; Ggita J; Berger CA; Kityamuwesi A; Sanyu AN; Tinka LK; Crowder R; Turyahabwe S; Katamba A; Cattamanchi A
    J Med Internet Res; 2023 May; 25():e38828. PubMed ID: 37252774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "99DOTS"techno-supervision for tuberculosis treatment - A boon or a bane? Exploring challenges in its implementation at a tertiary centre in Delhi, India.
    Prabhu A; Agarwal U; Tripathy JP; Singla N; Sagili K; Thekkur P; Sarin R
    Indian J Tuberc; 2020 Jan; 67(1):46-53. PubMed ID: 32192617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital Adherence Technologies Linked to Mobile Money Incentives for Medication Adherence Among People Living With Tuberculosis: Mixed Methods Feasibility and Acceptability Study.
    Musiimenta A; Tumuhimbise W; Atukunda E; Mugaba A; Linnemayr S; Haberer J
    JMIR Hum Factors; 2024 May; 11():e47996. PubMed ID: 38819905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the 99DOTS digital adherence technology on tuberculosis treatment outcomes in North India: a pre-post study.
    Chen AZ; Kumar R; Baria RK; Shridhar PK; Subbaraman R; Thies W
    BMC Infect Dis; 2023 Jul; 23(1):504. PubMed ID: 37525114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital Adherence Technologies and Differentiated Care for Tuberculosis Treatment and Their Acceptability Among Persons With Tuberculosis, Health Care Workers, and Key Informants in the Philippines: Qualitative Interview Study.
    Leung CL; Alacapa J; Tasca BG; Villanueva AD; Masulit S; Ignacio ML; Uy KN; Pell C; van Kalmthout K; Powers R; Fielding K; Jerene D
    JMIR Hum Factors; 2024 Jul; 11():e54117. PubMed ID: 39042889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda.
    Kiwanuka N; Kityamuwesi A; Crowder R; Guzman K; Berger CA; Lamunu M; Namale C; Kunihira Tinka L; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Patel D; Sammann A; Turyahabwe S; Dowdy DW; Katamba A; Cattamanchi A
    PLOS Digit Health; 2023 Jun; 2(6):e0000138. PubMed ID: 37390077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobile Health for Tuberculosis Management in South India: Is Video-Based Directly Observed Treatment an Acceptable Alternative?
    Kumar AA; De Costa A; Das A; Srinivasa GA; D'Souza G; Rodrigues R
    JMIR Mhealth Uhealth; 2019 Apr; 7(4):e11687. PubMed ID: 30942696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot project: 99DOTS information communication technology-based approach for tuberculosis treatment in Rajkot district.
    Thakkar D; Piparva KG; Lakkad SG
    Lung India; 2019; 36(2):108-111. PubMed ID: 30829243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and implementation challenges of using daily treatment regimens with an innovative adherence support tool among HIV-infected tuberculosis patients in Karnataka, India: a mixed-methods study.
    Thekkur P; Kumar AN; Chinnakali P; Selvaraju S; Bairy R; Singh AR; Nirgude A; Selvaraj K; Venugopal V; Shastri S
    Glob Health Action; 2019; 12(1):1568826. PubMed ID: 30712507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Accuracy of 99DOTS, a Novel Cellphone-based Strategy for Monitoring Adherence to Tuberculosis Medications: Comparison of DigitalAdherence Data With Urine Isoniazid Testing.
    Thomas BE; Kumar JV; Chiranjeevi M; Shah D; Khandewale A; Thiruvengadam K; Haberer JE; Mayer KH; Subbaraman R
    Clin Infect Dis; 2020 Dec; 71(9):e513-e516. PubMed ID: 32221550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare professionals' intention to adopt mobile phone-based SMS and its predictors for adherence support and care of TB patients in a resource-limited setting: a structural equation modelling analysis.
    Walle AD; Hunde MK; Demsash AW
    BMJ Open; 2023 Dec; 13(12):e070813. PubMed ID: 38149411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient-Provider Communication in the START Study.
    Hirsch-Moverman Y; Daftary A; Yuengling KA; Saito S; Ntoane M; Frederix K; Maama LB; Howard AA
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S37-S43. PubMed ID: 27930610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stakeholders' Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda: Exploratory Qualitative Study.
    Sekandi JN; Kasiita V; Onuoha NA; Zalwango S; Nakkonde D; Kaawa-Mafigiri D; Turinawe J; Kakaire R; Davis-Olwell P; Atuyambe L; Buregyeya E
    JMIR Mhealth Uhealth; 2021 Oct; 9(10):e27131. PubMed ID: 34704961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions and acceptability of short message services technology to improve treatment adherence amongst tuberculosis patients in Peru: a Focus Group Study.
    Albino S; Tabb KM; Requena D; Egoavil M; Pineros-Leano MF; Zunt JR; García PJ
    PLoS One; 2014; 9(5):e95770. PubMed ID: 24828031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral Predictors of Intention to Use a Text Messaging Reminder System Among People Living With HIV in Rural Uganda: Survey Study.
    Campbell JI; Aturinda I; Mwesigwa E; Habinka A; Kanyesigye M; Holden RJ; Siedner MJ; Kraemer JD
    JMIR Hum Factors; 2023 May; 10():e42952. PubMed ID: 37145834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
    Cattamanchi A; Crowder R; Kityamuwesi A; Kiwanuka N; Lamunu M; Namale C; Tinka LK; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Berger C; Tucker A; Patel D; Sammann A; Turyahabwe S; Dowdy D; Katamba A
    PLoS Med; 2021 May; 18(5):e1003628. PubMed ID: 33956802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.
    McNally TW; de Wildt G; Meza G; Wiskin CMD
    BMC Health Serv Res; 2019 Aug; 19(1):594. PubMed ID: 31438958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iterative Adaptation of a Tuberculosis Digital Medication Adherence Technology to Meet User Needs: Qualitative Study of Patients and Health Care Providers Using Human-Centered Design Methods.
    Patel D; Berger CA; Kityamuwesi A; Ggita J; Kunihira Tinka L; Turimumahoro P; Feler J; Chehab L; Chen AZ; Gupta N; Turyahabwe S; Katamba A; Cattamanchi A; Sammann A
    JMIR Form Res; 2020 Dec; 4(12):e19270. PubMed ID: 33289494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.